SATB1 and breast carcinoma: Likewise, McInnes et al. showed that FOXP3 induced miR-7 and miR-155 to target oncogenic SATB1 in BT549 breast cancer cells [203], whereas overexpression of miR-338-3p inhibited proliferation of hepatocellular carcinoma cells and induced cell cycle arrest partially through the downregulation of FOXP4 [30].